WT
ALXN

Washington Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Washington Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-91
Closed -$14K – 1071
2020
Q4 		$14K Sell
91
-8
-8% -$1.03K ﹤0.01% 720
2020
Q3 		$11K Hold
99
– – ﹤0.01% 723
2020
Q2 		$11K Sell
99
-15
-13% -$1.59K ﹤0.01% 644
2020
Q1 		$10K Buy
+114
New +$11.2K ﹤0.01% 674
2018
Q3 		– Sell
-176
Closed -$22K – 904
2018
Q2 		$22K Buy
+176
New +$20.6K ﹤0.01% 566

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Washington Trust's ALXN Position: Q1 2021 in Review

Washington Trust sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 91 shares — an estimated $14K sold.

Washington Trust first reported a position in ALXN in Q2 2018 and held it in 5 quarters. The position peaked at $22K in Q2 2018. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Washington Trust reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Washington Trust sold 91 Alexion Pharmaceuticals shares in Q1 2021, an estimated $14K.
  • Washington Trust first reported a position in Alexion Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • Washington Trust's Alexion Pharmaceuticals position peaked at $22K in Q2 2018.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Washington Trust's 13F filing for Q1 2021, filed 28 Apr 2021.